Faculty
Chief of Urologic Oncology
Hackensack University Medical Center
Hackensack, New Jersey
Expertise: Prostate Cancer, Kidney Cancer, Bladder Cancer, Ureter Cancer
FACULTY SESSIONS
-
Friday, February 19th 3:00–4:10 pm
Kidney Session II – Retroperitoneal – Single Port
PanelistThe retroperitoneal approach is technically feasible and safe for treatment of various urologic diseases, resulting in better cosmetic outcomes, lower postoperative analgesic requirements, and faster convalescence than is available with conventional laparoscopy, we will discuss the advantage and disadvantage of retroperitoneal single-site robot-assisted partial nephrectomy (R-SSRPN) using the da Vinci Xi surgical system.
To obtain additional details on Exhibiting at the symposium,
please contact Jennifer Berens, Gaffney Events
425.442.1314 | [email protected]
Presented by Mount Sinai Department of Urology in collaboration with Society of Urologic Robotic Surgeons and Endourological Society
